ATRi potentiates CD8+ T cell-dependent anti-tumor activity following conformal radiation in syngeneic CT26 tumors, despite transiently reducing activated CD8+ T cells in BALB/c host spleens (Vendetti et al., 2018). Here, CD8A is linked to neoplasm.